Follow The Filings

GALT position history

The shares of Galectin Therapeutics (GALT) that HORIZON KINETICS ASSET MANAGEMENT LLC reported in each quarter’s 13F.

Equity, COM NEW

Shares held by quarter

New Add Reduce Exit

  1. 2021 Q3: 24,000 shares, $93K, <0.01% of portfolio
  2. 2021 Q4: 24,000 shares, $50K, <0.01% of portfolio
  3. 2022 Q1: 26,000 shares, $42K, <0.01% of portfolio, Add +8.3%
  4. 2022 Q2: 26,000 shares, $34K, <0.01% of portfolio
  5. 2022 Q3: 26,000 shares, $42K, <0.01% of portfolio
  6. 2022 Q4: 52,000 shares, $59K, <0.01% of portfolio, Add +100.0%
  7. 2023 Q1: 56,000 shares, $118K, <0.01% of portfolio, Add +7.7%
  8. 2023 Q2: 56,000 shares, $81K, <0.01% of portfolio
  9. 2023 Q3: 56,000 shares, $108K, <0.01% of portfolio
  10. 2023 Q4: 53,742 shares, $89K, <0.01% of portfolio, Reduce −4.0%
  11. 2024 Q1: 53,742 shares, $128K, <0.01% of portfolio
  12. 2024 Q2: 53,742 shares, $121K, <0.01% of portfolio
  13. 2024 Q3: 51,484 shares, $142K, <0.01% of portfolio, Reduce −4.2%
  14. 2024 Q4: 53,742 shares, $69K, <0.01% of portfolio, Add +4.4%
  15. 2025 Q1: 53,742 shares, $66K, <0.01% of portfolio
  16. 2025 Q2: 51,484 shares, $109K, <0.01% of portfolio, Reduce −4.2%
  17. 2025 Q3: 53,742 shares, $228K, <0.01% of portfolio, Add +4.4%
  18. 2025 Q4: 51,484 shares, $214K, <0.01% of portfolio, Reduce −4.2%
  19. 2026 Q1: 49,226 shares, $137K, <0.01% of portfolio, Reduce −4.4%
  20. 2026 Q2: 46,968 shares, $218K, <0.01% of portfolio, Reduce −4.6%
Holdings date Value % of holdings Shares Filing date All 13F holders